Search Within

Roberta Zappasodi

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (5)
Groups
  1. Department of Medicine (12)
  2. Epidemiology and Biostatistics (12)
  3. GSK Faculty (12)
  4. Sloan Kettering Institute Postdocs (12)
  5. Melanoma and Immunotherapeutics Service (10)
  6. Solid Tumor Oncology Division (10)

More Groups

People
  1. Jedd Wolchok (10)
  2. Taha Merghoub (10)
  3. Sadna Budhu (7)
  4. Katherine Panageas (6)
  5. Cailian Liu (5)
  6. Daniel Hirschhorn Cymerman (5)

More People

Years
  1. 2022 (5)
  2. 2021 (1)
  3. 2020 (1)
  4. 2019 (1)
  5. 2018 (3)
  6. 2017 (1)
Publications
  1. Journal for ImmunoTherapy of Cancer (2)
  2. Journal of Clinical Investigation (2)
  3. Science Translational Medicine (2)
  4. Blood (1)
  5. Cancer Cell (1)
  6. Cancer Research (1)

More Publications

Publishers
  1. American Association for the Advancement of Science (2)
  2. American Society for Clinical Investigation (2)
  3. Biomed Central Ltd (2)
  4. American Association for Cancer Research (1)
  5. American Society of Hematology (1)
  6. Cell Press (1)

More Publishers

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
    Journal Article

    Ghosh, A.; Michels, J.; Mezzadra, R.; Venkatesh, D.; Dong, L.; Gomez, R.; Samaan, F.; Ho, Y. J.; Campesato, L. F.; Mangarin, L.; more...
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • Fundamental immune–oncogenicity trade-offs define driver mutation fitness
    Journal Article

    Hoyos, D.; Zappasodi, R.; Schulze, I.; Sethna, Z.; de Andrade, K. C.; Bajorin, D. F.; Bandlamudi, C.; Callahan, M. K.; Funt, S. A.; Hadrup, S. R.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT
    Journal Article

    Andrlová, H.; Miltiadous, O.; Kousa, A. I.; Dai, A.; DeWolf, S.; Violante, S.; Park, H. Y.; Janaki-Raman, S.; Gardner, R.; El Daker, S.; more...
    Science Translational Medicine (2022)

    Fulltext@MSK | Save
  • Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
    Journal Article

    Gigoux, M.; Holmström, M. O.; Zappasodi, R.; Park, J. J.; Pourpe, S.; Bozkus, C. C.; Mangarin, L. M. B.; Redmond, D.; Verma, S.; Schad, S.; more...
    Science Translational Medicine (2022)

    Fulltext@MSK | Save
  • Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions
    Journal Article

    Schad, S. E.; Chow, A.; Mangarin, L.; Pan, H.; Zhang, J.; Ceglia, N.; Caushi, J. X.; Malandro, N.; Zappasodi, R.; Gigoux, M.; more...
    Journal of Experimental Medicine (2022)

    Fulltext@MSK | Save
  • MAIT and Vδ2 unconventional T cells predict favorable outcome after allogeneic HCT and are supported by a diverse intestinal microbiome
    Meeting Abstract

    Andrlova, H.; Miltiadous, O.; Dai, A.; Gardner, R.; El Daker, S.; Slingerland, J. B.; Giardina, P. A.; Clurman, A.; Gomes, A. L. C.; Nguyen, C. L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Overcoming immune resistance with rationally designed combination immunotherapy
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Sirard, C.; Qi, J.; Liu, C.; Li, Y.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Zhong, H.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
    Journal Article

    Khalil, D. N.; Suek, N.; Campesato, L. F.; Budhu, S.; Redmond, D.; Samstein, R. M.; Krishna, C.; Panageas, K. S.; Capanu, M.; Houghton, S.; more...
    Journal of Clinical Investigation (2019)

    Fulltext@MSK | Save
  • Modulation of T(FH)-like cells and anti-tumor activity of immune checkpoint blockade
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save